From concept to chemistry: integrating protection group strategy and reaction feasibility into non-natural amino acid synthesis planning
Artikel i vetenskaplig tidskrift, 2025

Incorporating non-natural amino acids (NNAAs) into peptides enhances therapeutic properties, including binding affinity, metabolic stability, and in vivo half-life time. The pursuit of novel NNAAs for improved peptide designs faces the challenge of effective synthesis of these building blocks as well as the entire peptide itself. Solid-Phase Peptide Synthesis (SPPS) is an essential technology for the automated assembly of peptides with NNAAs, necessitating careful protection for effective coupling of amino acids in the peptide chain. This process requires orthogonal protection of the reactive groups in individual amino acids after synthesizing them, presenting a challenge in bridging in silico peptide design with chemical synthesis. To address this, we have developed a first-of-its-kind synthesis assistance tool, NNAA-Synth, that plans and evaluates the synthesis of individual SPPS-compatible NNAAs. Our tool unifies (i) introducing orthogonal protecting groups to NNAAs, (ii) retrosynthetic prediction to propose synthesis routes, and (iii) scoring the synthetic feasibility of these routes. We demonstrate how the tool facilitates optimal protection strategy selection for individual NNAAs. Additionally, it enables synthesizability-aware NNAA ranking and prioritization during computational screening, enhancing the quality of the in silico design by assessing the accessibility of individual building blocks.

Författare

Gökçe Geylan

Chalmers, Life sciences, Systembiologi

Mikhail Kabeshov

AstraZeneca AB

Samuel Genheden

AstraZeneca AB

Christos Kannas

AstraZeneca AB

Thierry Kogej

AstraZeneca AB

Leonardo De Maria

AstraZeneca AB

Florian David

Chalmers, Life sciences, Systembiologi

Ola Engkvist

Chalmers, Data- och informationsteknik, Data Science och AI

Göteborgs universitet

Chemical Science

2041-6520 (ISSN) 2041-6539 (eISSN)

Vol. In Press

AI-guidad design för cykliska peptidläkemedel

Stiftelsen för Strategisk forskning (SSF) (ID20-0109), 2021-01-01 -- 2025-01-01.

Ämneskategorier (SSIF 2025)

Organisk kemi

DOI

10.1039/d5sc04898b

PubMed

40927006

Mer information

Senast uppdaterat

2025-09-26